JP2014500252A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014500252A5 JP2014500252A5 JP2013538052A JP2013538052A JP2014500252A5 JP 2014500252 A5 JP2014500252 A5 JP 2014500252A5 JP 2013538052 A JP2013538052 A JP 2013538052A JP 2013538052 A JP2013538052 A JP 2013538052A JP 2014500252 A5 JP2014500252 A5 JP 2014500252A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridin
- methyl
- ylamino
- phenoxy
- methylsulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010535640 | 2010-11-09 | ||
| CN201010535640.4 | 2010-11-09 | ||
| PCT/CN2011/082004 WO2012062210A1 (en) | 2010-11-09 | 2011-11-09 | Compound for increasing kinase active and application thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014500252A JP2014500252A (ja) | 2014-01-09 |
| JP2014500252A5 true JP2014500252A5 (enExample) | 2014-12-25 |
| JP6038037B2 JP6038037B2 (ja) | 2016-12-07 |
Family
ID=46050413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013538052A Expired - Fee Related JP6038037B2 (ja) | 2010-11-09 | 2011-11-09 | キナーゼ活性を増加させるための化合物とその応用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9409900B2 (enExample) |
| EP (1) | EP2638036B1 (enExample) |
| JP (1) | JP6038037B2 (enExample) |
| KR (2) | KR101643721B1 (enExample) |
| CN (1) | CN103502244B (enExample) |
| AU (1) | AU2011328673B2 (enExample) |
| SG (2) | SG190784A1 (enExample) |
| WO (1) | WO2012062210A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR127073A1 (es) | 2021-09-17 | 2023-12-13 | Flagship Pioneering Innovations Vi Llc | Composiciones y métodos para producir polirribonucleótidos circulares |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3632042A1 (de) | 1986-03-08 | 1987-09-10 | Bayer Ag | Diarylsulfidderivate |
| JPS62212378A (ja) * | 1986-03-08 | 1987-09-18 | バイエル・アクチエンゲゼルシヤフト | ジアリ−ルスルフイド誘導体 |
| US6719520B2 (en) | 1998-10-08 | 2004-04-13 | Smithkline Beecham Corporation | Method and compounds |
| JP2002527419A (ja) * | 1998-10-08 | 2002-08-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Ｇｓｋ−３阻害物質としてのピロール−２，５−ジオン類 |
| UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
| EP1127882A1 (en) * | 2000-01-25 | 2001-08-29 | Pfizer Products Inc. | Tetrazole compounds as thyroid receptor ligands |
| GB0008264D0 (en) * | 2000-04-04 | 2000-05-24 | Smithkline Beecham Plc | Novel method and compounds |
| JP3598994B2 (ja) * | 2000-07-10 | 2004-12-08 | セイコーエプソン株式会社 | 電気光学装置の製造方法 |
| ES2263743T3 (es) * | 2001-04-13 | 2006-12-16 | Pfizer Products Inc. | Derivados de 4-aminopiridopirimidina sustituidos con un grupo biciclico. |
| WO2003026665A1 (en) * | 2001-09-26 | 2003-04-03 | Bayer Pharmaceuticals Corporation | 2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors |
| DE10153396A1 (de) * | 2001-11-01 | 2003-05-28 | Siemens Ag | Einrichtung zur Ansteuerung einer elektrischen Kraftstoffpumpe |
| KR100768609B1 (ko) * | 2003-07-09 | 2007-10-18 | 에프. 호프만-라 로슈 아게 | 티오페닐아미노이미다졸린 |
| BRPI0517232A (pt) * | 2004-11-02 | 2008-10-07 | Banyu Pharma Co Ltd | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, ativador da glicocinase, e, agentes terapêuticos e/ou profiláticos para diabetes e para obesidade |
| US20120052061A1 (en) * | 2007-09-24 | 2012-03-01 | Tragara Pharmaceuticals Inc. | Therapies for treating cancer using combinations of cox-2 inhibitors and anti-her2(erbb2) antibodies or combinations of cox-2 inhibitors and her2(erbb2) receptor tyrosine kinase inhibitors |
| WO2010090875A1 (en) * | 2009-01-21 | 2010-08-12 | Rigel Pharmaceuticals, Inc. | Derivatives of n2-(3-pyridil or phenyl)-n4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases |
-
2011
- 2011-11-09 EP EP11839459.2A patent/EP2638036B1/en active Active
- 2011-11-09 AU AU2011328673A patent/AU2011328673B2/en not_active Ceased
- 2011-11-09 WO PCT/CN2011/082004 patent/WO2012062210A1/en not_active Ceased
- 2011-11-09 KR KR1020157025687A patent/KR101643721B1/ko not_active Expired - Fee Related
- 2011-11-09 CN CN201180053876.7A patent/CN103502244B/zh active Active
- 2011-11-09 US US13/884,470 patent/US9409900B2/en active Active
- 2011-11-09 SG SG2013036041A patent/SG190784A1/en unknown
- 2011-11-09 JP JP2013538052A patent/JP6038037B2/ja not_active Expired - Fee Related
- 2011-11-09 SG SG10201509157QA patent/SG10201509157QA/en unknown
- 2011-11-09 KR KR1020137014756A patent/KR20140016245A/ko not_active Ceased